ArticlePolymers2025
A 3D-Printed Aqueous Drainage Tube with an Expandable Inner Diameter to Accommodate the Intraocular Pressure (IOP) Fluctuations After Glaucoma Surgery.
Article in Polymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Glaucoma treatment involves reducing the intraocular pressure (IOP), which can damage the optic nerve, to a normal range. Aqueous drainage devices may be used for treatment, and a variety of devices have been proposed. However, they have a non-variable and uniform inner diameter, which makes it difficult to accommodate the IOP fluctuations that occur after glaucoma surgery. To ensure effective treatment in the early post-operative period with low IOP and the late post-operative period with high IOP, the inner diameter should be expandable over time to allow for smooth aqueous drainage. Here, we applied 3D printing technology with a tri-axial nozzle to develop an aqueous drainage tube that can expand its inner diameter. The distinct bilayer structure of the device allows it to expand its inner diameter through biodegradation, which can accommodate the IOP fluctuations that often occur after glaucoma surgery. The fabricated structure was evaluated in a series of tests, including leakage, cytotoxicity, and degradation experiments. The device did not show any leakage, was not toxic to cells, and demonstrated the expansion of the inner diameter through biodegradation. The device may provide a more effective post-operative solution for glaucoma patients by alleviating the effects of low IOP in the early post-operative period and high IOP in the late post-operative period.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.